In relation to this, MT2A is considered a key player in the maintenance of immune homeostasis (Jakovac et al., 2013) and its involvement as a neuroprotective factor has been described in different neurodegenerative diseases such as Parkinson's disease (Miyazaki et al., 2013), Alzheimer's disease (Chung et al., 2010), or amyotrophic lateral sclerosis (Brandebura et al., 2023). This evidence concerns the gene MT2A and neurodegenerative disease.